Skip to main content
Translational Oncology logoLink to Translational Oncology
. 2026 Sep 9;73:103024. doi: 10.1016/j.tranon.2026.103024

Corrigendum to “Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer” [Transl Oncol. 2023 Jan;27:101598]

Han Shuwen a, Wang Yangyanqiu b, Chu Jian c, Hu Boyang c, Chen Gong d, Zhuang Jing d,⁎
PMCID: PMC13679621  PMID: 42855220

Revised author list:

Han Shuwen 1, Chu Jian 2, Hu Boyang 2, Chen Gong 3, Zhuang Jing 4

  • 1.

    Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, Zhejiang Province, PR China; Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou, Zhejiang Province, PR China.

  • 2.

    Zhejiang Chinese Medical University, Zhejiang Province, PR China.

  • 3.

    Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, Zhejiang Province, PR China.

  • 4.

    Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, Zhejiang Province, PR China. Electronic address: ww@hzhospital.com.

Corrigendum text: Following publication of the original article, Yangyanqiu Wang is removed from the author list. The Acknowledgements section of the original article has been supplemented with the statement: “The authors acknowledge Yangyanqiu Wang for his comments and suggestions during the preparation of this work.” This revision does not alter the scientific conclusions of the original article, and the online version of the article has been updated accordingly.

The authors would like to apologise for any inconvenience caused.


Articles from Translational Oncology are provided here courtesy of Neoplasia Press

RESOURCES